Search

Select theme:

Shopping cart

Subtotal
$97.00
View cart Checkout

Saved articles

You have not yet added any article to your bookmarks!

Browse articles
Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

GDPR Compliance

We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

  • Home
Phase II Clinical Development of New Drugs

Phase II Clinical Development of New Drugs

By Naitee Ting, Ding-Geng Chen, Shuyen Ho & Joseph C. Cappelleri Medical 08/04/2017

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.

Read More
More Books from Naitee Ting, Ding-Geng Chen, Shuyen Ho & Joseph C. Cappelleri
Dose Finding in Drug Development Naitee Ting
Dose Finding in Drug Development
Design and Analysis of Subgroups with Biopharmaceutical Applications Naitee Ting, Joseph C. Cappelleri, Shuyen Ho & (Din) Ding-Geng Chen
Design and Analysis of Subgroups with Biopharmaceutical Applications
Applied Statistics in Biomedicine and Clinical Trials Design Zhen Chen, Aiyi Liu, Yongming Qu, Larry Tang, Naitee Ting & Yi Tsong
Applied Statistics in Biomedicine and Clinical Trials Design
Phase II Clinical Development of New Drugs Naitee Ting, Ding-Geng Chen, Shuyen Ho & Joseph C. Cappelleri
Phase II Clinical Development of New Drugs
Comments